# Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing

> **NCT07384767** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, Davis** · enrollment: 220 (estimated)

## Conditions studied

- Mohs Micrographic Surgery
- Excision Margin

## Interventions

- **DRUG:** Timolol 0.5% Ophthalmic Solution
- **OTHER:** Hydrogel of placebo

## Key facts

- **NCT ID:** NCT07384767
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07384767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07384767, "Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07384767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*